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Introduction
The single-pass VDD pacing lead affords reliable long-term atrial sensing and consistent atrioventricular (AV) synchrony, and has been accepted as a pacing mode for patients with symptomatic AV block but normal sinus node function. [1] [2] [3] In properly selected patients, VDD pacemakers maintain AV synchrony and a chronotropic response to exercise and stress. [4] [5] [6] However, atrial faulty sensing remains a vexing problem despite improved atrial-lead design and electrode placement. To achieve stable atrial sensing, a selection of the electrode with the optimal AV distance (AVD) is important. Since heart sizes differ, leads with various AVDs are provided by the manufacturers.
Conventionally, the operator estimates proper lead size based on superimposing the leads over the chest x-ray film prior to implantation (chest xray method), but this is unsatisfactory. 7 Two new methods have been described to improve selection of the best fitting electrode length, but in the authors' opinion both of them are time-consuming and expose patients to additional irradiation hazard. [7] [8] [9] The authors hypothesized that the size of the right heart chambers, instead of the cardiac silhouette on chest X ray, may be an important factor that affects atrial sensing. Since echocardiographic examination can provide noninvasive visualization of the cardiac chambers and allows direct measurement of their internal dimensions, an echocardiographic method was developed for choosing the proper AVD.
Patients and Methods Study Patients
Twenty-six consecutive patients (12 men, 14 women) aged 30-82 years (mean 68 6 13 years) who had undergone permanent VDD pacemaker implantation between July 1996 and July 1998 for symptomatic high degree AV block and normal sinus node function were selected for this study.
Development of an Echocardiographic Method for Choosing the Best Fitting Single-Pass VDD Lead
Clinical symptoms related to significant bradycardia included dizziness, weakness, syncope, and exacerbation of congestive heart failure. The heart size of the patients was assessed by chest X ray before implantation and the selection of AVD was based on the above-mentioned conventional chest x-ray method.
Pacemaker Implantation
One of two VDD pacing systems was chosen for each patient: Unity, 292-07 (Intermedics, Inc., Angleton, TX, USA) and Thera VDD 8948 (Medtronic, Inc., Minneapolis, MN, USA). The leads were implanted using a conventional technique under local anesthesia. The lead was inserted into the cephalic vein or the subclavian vein and then passed under fluoroscopic control until the electrode tip was placed within the right ventricular apex and the atrial electrodes within the mid to high right atrium. After the tip was positioned in the right ventricular apex, the ventricular pacing and sensing thresholds were determined using the pacing system analyzer model 5311B (Medtronic, Inc.) or model 4800 (PACE Medical, Inc., Waltham, MA, USA). A pacing threshold , 1.0 V at a pulse duration of 0.5 ms and a sensing threshold $ 5.0 mV was accepted. Then the atrial sensing threshold was determined. The position of the atrial dipole with the largest sensing threshold during deep respiration was taken. At predischarge, the atrial sensing threshold was determined again using the programmer model 9790C (Medtronic, Inc.) or model RX5000 (Intermedics, Inc.) and the pacemaker was programmed to the highest atrial sensitivity level to avoid oversensing. The atrial sensing threshold was defined to be optimal (mean minimum P wave $ 1.0 mV) or suboptimal (mean minimum P wave , 1.0 mV) for each patient.
Echocardiography
Transthoracic echocardiographic evaluations were routinely performed prior to invasive procedures, including permanent pacemaker implantation. The ultrasound imaging used in this study was performed by a commercially available ultrasound system (SONOS 5500, Hewlett Packard Co., Palo Alto, CA, USA) with a 2.5-or 3.5-MHZ transducer and was recorded on videotape (player model MD-830, Panasonic). The average interval between pacemaker implantation and echocardiographic examination was 3 6 1 days. Having the imaging on videotapes allowed the study to be performed retrospectively.
The authors retrieved those patients' ultrasound imaging and measured their internal dimensions of right heart chambers at end-diastole (RHIDd) offline. The apical four chamber view with the largest right atrial and ventricular areas, determined by eye, was chosen for measurement, and the RHIDd was defined as the longest straight distance between the right ventricular apex and the posterior wall of the right atrium during enddiastole in the apical four chamber view (Fig. 1) . Measurements from at least three different cardiac cycles were made and averaged. The authors then derived a cut-off point of RHIDd measurements and determined a selection criterion for choosing the proper AVD.
To evaluate the feasibility of echocardiographic measurement of RHIDd, the ultrasound imaging of 25 subjects was measured independently by two experienced examiners. Intraobserver variability of the measurement was also evaluated for the same patients.
Statistical Analysis
Values are expressed as mean 6 SD. Values were significant when P , 0.05. The interobserver YIN, ET AL. and intraobserver variability of RHIDd measurement was determined using the SAS software package, version 6.12 (SAS Institute Inc., Cary, NC, USA). Correlations were assessed by the intraclass correlation method.
Results

Clinical Characteristics of Study Patients
The permanent lead was inserted into the left cephalic vein in 10 patients and into the subclavian vein in 16 patients (1 right, 15 left). Correct positioning of the lead tip in the right ventricular apex was achieved in all patients. The ventricular pacing threshold was 0.5 6 0.2 V at a pulse duration of 0.5 ms. The R wave amplitude measured 12.7 6 4.9 mV. Clinical data of the patients is given in Table I .
Based on the conventional chest x-ray method, a lead with an AVD of 13 cm (425-04, Intermedics) or 13.5 cm (5032, Medtronic) was used for implantation in 22 patients. A lead with an AVD of 16 cm (425-06, Intermedics) was used in the other four patients. In two cases the AVD was overestimated and a greater loop had to be formed with the lead within the right atrium to obtain atrial sensing which, although achieved, remained suboptimal in both cases. Overall, the chest x-ray method properly selected a lead with optimal atrial sensing for only 20 (77%) of 26 patients. In all six patients with suboptimal atrial sensing, their atrial bipolar sensitivity setting subsequently needed to be reprogrammed to 0.18 mV to maintain sensing. One of them was eventually reprogrammed to the VVIR mode owing to loss of atrial sensing.
Development of the Echocardiographic Method
By plotting all 26 selected AVD on a graph against their respective RHIDd, a clear cut-off point could be seen: RHIDd 13 cm (Fig. 2) . Above this point, atrial sensing was optimal only for large (16 cm) AVDs (2 cases); below this point, sensing was optimal only for smaller (13 F 5 female; M 5 male; 1 5 enlarged; N 5 normal assessed by chest X ray; AVD 5 AV distance; MPWA 5 minimum P wave amplitude; RHIDd 5 internal dimensions of right heart chambers at end-diastole.
AVD were smaller above this point (four cases) or large below this point (two cases), atrial sensing was suboptimal. If we were to use this 13-cm cutoff in the RHIDd as a criterion for lead selection, all 6 (23%) of 26 patients with suboptimal atrial sensing would be identified and classified as having missized leads. That is to say, that by using the chest x-ray method, the authors had erroneously chosen the AVD by overestimating it for patients 4 and 21, and underestimating it for patients 3, 7, 9, and 23.
The maximum examination time for the echocardiographic RHIDd measurement was 5 6 2 minutes. The correlation coefficient for interobserver variability of the measurement was 0.859 (P , 0.001) and that for intraobserver variability was 0.941 (P , 0.001).
Discussion
The hemodynamic and clinical benefits of single-pass VDD pacing have been well described in studies after the system was first described for clinical application in the early 1980s.
1,2 However, atrial faulty sensing is still considered to be one of the more troublesome problems associated with VDD pacemakers. Many factors, like respiration, body position, electrode movement in the right atrium, exercise, and so forth have been reported to affect atrial sensing.
4,10-12 Ovsyshcher et al. 10 reported that to achieve stable single lead VDD pacing, selection of the electrode with the optimal AVD is important. Choosing the wrong electrode with a suboptimal AVD may result in an unfavorable position of the atrial dipole with insufficient atrial sensing. Although the use of a more sensitive atrial bipolar sensitivity setting can lower the occurrence of undersensing, a second lead with a different AVD may be needed, prolonging implantation time and producing additional costs. 10 Since heart sizes differ, leads with various AVDs are used, ranging from 9.6 to 17.5 cm. 1 As the pacing lead travels within the right heart chambers, the authors hypothesized that the size of the right atrium and right ventricle, instead of their left-sided counterparts, is one of the major factors that affect the sensing function of the floating atrial dipole in VDD pacing leads.
Anatomically, the right ventricle lies directly beneath the sternum. The chamber has an irregular shape, the walls are trabeculated, and the location of the chamber within the chest may vary significantly depending on the position of the patient and the presence of cardiac diseases. The conventional chest x-ray method superimposes the leads over the patient's x-ray view to estimate proper lead size, but it results in significant bias. 2, 7, 9 Since the heart is a three-dimensional structure, and we see only two borders in any one view, it is necessary to secure films in several projections of the various chambers for it to be brought into profile. For example, the right ventricle is not borderforming on the frontal projection; an enlargement of the right ventricle is best appreciated on the lateral projection. In addition, the contours of the heart chambers merge with each other, and it is difficult to determine, on the film, the point of transition between the right and left ventricle, that is, to determine where the right ventricular apex actually is. These formidable problems make accurate measurements of cardiac chamber size on X rays difficult. Thus, it is not surprising that if one tries to select a pacing lead (which courses a threedimensional curvilinear route in the right heart) based on two-dimensional chest x-ray projections, up to 6 (23%) of 26 patients in this study have missized AVDs. Even though this is much better than the results reported by Gessman et al., 7 it is still unsatisfactory.
In 1995, two methods were proposed to improve selection of the best fitting electrode length. Gessman et al. 7 used a temporary lead with atrial bipolar pairs at different setback spacings to record the amplitude of atrial electrograms prior to implantation, and chose a permanent lead with the same AVD that recorded the largest minimum amplitude. Using the new method, 26 of 27 patients achieved long-term proper P sensing. 7 Nowak et al. 8, 9 described another method using a test electrode with an AVD of 13 cm taped onto the thorax of the patient, and determined the AVD by manipulation of the test electrode under fluoroscopy. The atrial dipole of the finally chosen permanent lead was placed in an ideal position in all cases. 8, 9 However, the authors of the present study considered both methods to be time-consuming and to expose the patients to additional irradiation hazards.
Given that echocardiography provides a much clearer view of the internal structures of the heart than do X rays, the authors hypothesized that if a measurement could be found which was straightforward to perform and consistent in its results, such a measurement could be used to select AVD with a significantly greater rate of success than the conventional chest x-ray method. They chose to use the apical four chamber view for two reasons. First, the permanent pacemaker electrode is deliberately enmeshed and anchored in trabeculae of the right ventricle, which can best be visualized in this view. Second, both right heart chambers can be visualized together in this single view. In addition, because extensive trabeculation in the right ventricle normally partially obliterates the cavity during systole, they chose to measure the internal dimensions of the right heart chambers at end-diastole for better visualization of the right ventricular apex (Fig. 3) . If one takes measurements, during end-diastole in the apical four chamber view, of the straight distance from the right ventricular apex to different points along the posterior wall of the right atrium, the distance measured will vary from point to point; RHIDd was defined as the largest such measurement that could be found. As the path the pacing lead courses is three-dimensional and curvilinear, and the mid to high right atrium is considered to be the best position of the atrial dipole, 13, 14 the AVD should always be longer than the RHIDd measured (Fig. 4) . For this reason, a lead with an AVD of 13 or 13.5 cm should only be selected if the RHIDd is , 13 cm.
In the present study, echocardiography does provide a more precise measurement of the dimensions of the right heart chambers than a chest X ray, and all six cases with suboptimal atrial sensing can be identified as having had chosen a suboptimal AVD for their right heart chambers. The six cases with missized leads can further be classified as those who have an undersized AVD (four cases) and those who have an oversized AVD (two cases). All four patients with undersized electrode distances had chronic right heart chamber dilatation owing to various cardiac diseases (ischemic cardiomyopathy in 1, rheumatic heart disease s/p mitral valve replacement and chronic both-sided heart failure in 2, and dilated cardiomyopathy in 1). Taking these four cases in conjunction with the two whose large AVDs were optimal (patients 6 and 19, both of whom also had dilated right heart chambers) suggests that a lead with an AVD of 15.5 or 16 cm would be suitable for those patients with chronic dilatation of right heart chambers owing to various conditions. This means a larger AVD may be needed in 6 (23%) of 26 patients who undergo VDD pacemaker implantation. In other studies, the use of a larger AVD is reported with an incidence ranging from 6.6% to 25% of patients. [7] [8] [9] [10] 13 This may be informative to the manufacturers, who should be aware of the number of leads with different AVDs to be supplied on the market.
As to the two patients with overestimated AVDs, one of them (patient 21) had marked reduction of heart size after successful treatment of an episode of acute pulmonary edema. Based on the chest X ray taken on day 3 postadmission, the AVD was overestimated and a large loop had to be formed with the lead within the right atrium to obtain atrial sensing. When the echocardiographic imaging was retrieved, the RHIDd measured was only 11.4 cm. In the other patient (patient 4), a lead with an AVD of 16 cm was chosen because he had an enlarged cardiac silhouette on the chest X ray, but later it was found to be suboptimal. The RHIDd, measured by echocardiography retrospectively, was 12.3 cm. The first case suggests that a chest X ray on the operation day rather than earlier may be helpful in choosing the proper AVD. However, selection of a best-fitting lead would be better based on the echocardiographic method when the heart size is significantly enlarged on chest X ray, because the echocardiographic method can better differentiate which chamber(s) is (are) enlarged and can measure the RHIDd more accurately. Good interobserver and intraobserver variability were documented with the RHIDd measurement and the maximum examination time is only 5 minutes. This promises to be a simple, noninvasive, and reliable method of VDD lead selection.
Study Limitations
The designs of the floating atrial dipole are different in the two single-pass VDD pacing systems chosen for the studied patients. [15] [16] [17] [18] The Unity system has a diagonally displaced dipole and the Thera system has ring electrodes for atrial sensing. The AVD of the Intermedics leads are 11, 13, and 16 cm and those of the Medtronic leads are 11.5, 13.5, and 15.5 cm. So the different lead designs might, to some extent, produce different atrial sensing results for the same patient. For example, there might have been a better atrial sensing in those who had suboptimal results using an Intermedics lead with 13 cm AVD had a Medtronic lead with 13.5 cm AVD been used instead, or vice versa, especially in a patient with borderline enlarged right heart chambers.
No conclusion can be drawn from the present study of the patient with reduced heart size. That is to say, the criterion for selection of a lead with an AVD of 11 or 11.5 cm cannot be derived from this small statistical population. However, considering that patients with congenital heart block are good candidates for VDD pacing, 19 study in this area would be worthwhile.
Although the results in this study are encouraging, it was a retrospective study of a limited number of cases. A larger prospective study is needed to verify its clinical use. However, the preliminary results that have been reported are also encouraging.
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Conclusions
The described echocardiographic method provides a simple, noninvasive, and promising YIN, ET AL.
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May 2002 PACE, Vol. 25, No. 5 preoperative assessment of the proper electrode length in single lead VDD pacing. However, a prospective study in a larger population of patients is needed to verify its applicability. 
